News
Category: CTAD
IXICO strengthens Scientific Advisory Board with two prominent global Alzheimer’s Disease and vascular experts
Appointments announced at 2025 CTAD Conference forms part of a concerted dementia research and product innovation strategy, particularly in the area of vascular biomarkers 01 December 2025, IXICO plc (AIM: IXI) – London, UK.